Testicular failure, medically known as primary hypogonadism, is a condition where the testes are unable to produce sufficient levels of testosterone or sperm. For men, this diagnosis can feel deeply personal and challenging, affecting physical energy, mood, and sexual confidence. Symptoms often develop slowly, manifesting as chronic fatigue, reduced muscle mass, or a loss of libido, which can be easily mistaken for general aging or stress. It is a medical condition rooted in the body’s endocrine system, not a reflection of masculinity or effort.

Treatment is vital because testosterone does far more than regulate sex drive; it helps maintain bone density, red blood cell production, and emotional stability. By restoring hormone levels to a healthy range, treatment can reverse many distressing symptoms and protect long-term health. Because the underlying causes range from genetic factors to injury or infection, treatment plans are tailored to the individual’s age, health goals, and desire for fertility (MedlinePlus, 2022).

Overview of treatment options for Testicular Failure

The primary goal of treating testicular failure is Testosterone Replacement Therapy (TRT). Since the testes are no longer capable of producing adequate hormones on their own, the medical approach is to introduce testosterone from an external source. This restores the body’s levels to a physiologic “normal” range.

For men who desire fertility, the approach is more complex. Because standard testosterone therapy halts sperm production, it is generally not suitable for men actively trying to conceive. In such cases, alternative medications may be attempted to stimulate any remaining testicular function, though success rates vary in primary failure compared to other forms of hypogonadism. For the vast majority of patients, however, the focus is on lifelong hormone replacement to manage symptoms and prevent complications like osteoporosis (Endocrine Society, 2022).

Medications used for Testicular Failure

Testosterone Replacement Therapy (TRT) is the gold standard drug class for this condition. It is available in several delivery methods to suit different lifestyles and preferences.

Transdermal Gels and Patches: These are among the most commonly prescribed options. Gels are applied daily to the skin (shoulders, arms, or abdomen), allowing the hormone to be absorbed gradually into the bloodstream. Clinical experience suggests that gels provide stable hormone levels without the “peaks and valleys” sometimes seen with injections.

Injectable Testosterone: Testosterone cypionate and testosterone enanthate are esters injected into the muscle or under the skin. Depending on the formulation, injections are typically given every one to two weeks. This method is often less expensive and ensures 100% medication compliance.

Buccal or Nasal Systems: These are newer options where medication is applied to the gums or sprayed into the nose. They require multiple daily doses but offer an alternative for those who dislike needles or gels.

Patients typically notice an improvement in energy and libido within a few weeks of starting therapy. Physical changes, such as increased muscle mass and decreased body fat, generally take three to six months to become noticeable (Mayo Clinic, 2023).

How these medications work

Testosterone replacement therapy (TRT) directly substitutes for the hormone the body fails to produce. In testicular failure, the pituitary signal is sent, but the testes cannot respond. TRT bypasses this failure by supplying testosterone directly.

Restoring blood testosterone levels reactivates androgen receptors, signaling bones to retain calcium, muscles to synthesize protein, and the brain to regulate mood and libido. Essentially, TRT refills the body’s essential “fuel tank,” allowing normal function to resume.

Side effects and safety considerations

While effective, TRT requires careful monitoring. Common side effects include acne, fluid retention, and mood swings. A key concern is polycythemia (excessive red blood cells, thickening blood), which raises the risk of clots; doctors monitor blood counts.

Topical gels carry a risk of transfer, so women and children must avoid contact with the application site. TRT suppresses sperm production, often causing infertility. Men with a history of prostate or breast cancer should usually avoid testosterone. Patients must seek medical attention for chest pain, shortness of breath, or signs of deep vein thrombosis (swelling in one leg).

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. Endocrine Society. https://www.endocrine.org
  2. Mayo Clinic. https://www.mayoclinic.org
  3. MedlinePlus. https://medlineplus.gov
  4. Urology Care Foundation. https://www.urologyhealth.org

Medications for Testicular Failure

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Testicular Failure.

Found 5 Approved Drugs for Testicular Failure

Follitropin

Brand Names
Follistim, Gonal-f RFF Redi-ject, Gonal-f

Follitropin

Brand Names
Follistim, Gonal-f RFF Redi-ject, Gonal-f
Gonal-F is indicated for: GONAL-F is a gonadotropin indicated for: Women: Induction of ovulation and pregnancy in oligo-anovulatory infertile women for whom the cause of infertility is functional and not due to primary ovarian failure.

Undecanoate

Brand Names
Kyzatrex, Jatenzo, Tlando, Aveed

Undecanoate

Brand Names
Kyzatrex, Jatenzo, Tlando, Aveed
TLANDO is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle stimulating hormone (FSH), luteinizing hormone (LH)) above the normal range [see Dosage and Administration.

Xyosted

Generic Name
Enanthate

Xyosted

Generic Name
Enanthate
XYOSTED (testosterone enanthate) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations but have gonadotropins in the normal or low range. Limitations of Use: Safety and efficacy of XYOSTED in males less than 18 years old have not been established [see Use in Specific Populations.

MethylTESTOSTERone

Brand Names
Estratest, Methitest

MethylTESTOSTERone

Brand Names
Estratest, Methitest
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE FULL STRENGTH and ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH are indicated in the treatment of: Moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone. (There is no evidence that estrogens are effective for nervous symptoms or depression without associated vasomotor symptoms, and they should not be used to treat such conditions.) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE FULL STRENGTH and ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH HAVE NOT BEEN SHOWN TO BE EFFECTIVE FOR ANY PURPOSE DURING PREGNANCY AND ITS USE MAY CAUSE SEVERE HARM TO THE FETUS (SEE BOXED WARNING ).

Cypionate

Brand Names
Depo-Estradiol, Depo-Testosterone, Azmiro

Cypionate

Brand Names
Depo-Estradiol, Depo-Testosterone, Azmiro
Testosterone Cypionate Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) - testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. Hypogonadotropic hypogonadism (congenital or acquired) - gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. Safety and efficacy of Testosterone Cypionate Injection in men with “age­-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established.
Showing 1-5 of 5
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances